Basit öğe kaydını göster

dc.contributor.authorSagirli, O.
dc.contributor.authorSENSOY, Demet
dc.contributor.authorOenal, Armağan
dc.date.accessioned2021-03-06T12:28:07Z
dc.date.available2021-03-06T12:28:07Z
dc.identifier.citationOenal A., Sagirli O., SENSOY D., "Selective LC determination of cabergoline in the bulk drug and in tablets: In vitro dissolution studies", CHROMATOGRAPHIA, cilt.65, ss.561-567, 2007
dc.identifier.issn0009-5893
dc.identifier.otherav_f3fefe6c-f8cf-4969-b612-d67a3165baff
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/159983
dc.identifier.urihttps://doi.org/10.1016/s0009-5893(07)82061-3
dc.description.abstractCabergoline (CAB) is an ergot alkaloid derivative with dopamine agonist activity. A novel, simple, and rapid stability-indicating high-performance liquid chromatographic (HPLC) method for assay of CAB in tablets has been developed and validated. Chromatography was performed on a 4.6 mm i.d. x 250 mm, 5 mu m particle, cyano column with acetonitrile-10 mM phosphoric acid, 35:65 (v/v), containing 0.04% triethylamine, as mobile phase, at a flow rate of 1.0 mL min(-1), and UV detection at 280 nm. Response was a linear function of concentration in the range 0.1-4 mu g mL(-1) (r(2) = 0.9999). The recovery of the method was good (99.45%) and RSD values for intra-day and inter-day precision were 0.24-0.88% and 0.66-1.19%, respectively. The method can be used for quality-control assay of CAB in tablets, for stability studies, and for in vitro dissolution studies.
dc.language.isoeng
dc.subjectKİMYA, ANALİTİK
dc.subjectKimya
dc.subjectTemel Bilimler (SCI)
dc.subjectBİYOKİMYA VE MOLEKÜLER BİYOLOJİ
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectBiyokimya
dc.subjectYaşam Bilimleri
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectSitogenetik
dc.subjectAnalitik Kimya
dc.subjectTemel Bilimler
dc.subjectBİYOKİMYASAL ARAŞTIRMA YÖNTEMLERİ
dc.subjectBiyoloji ve Biyokimya
dc.subjectYaşam Bilimleri (LIFE)
dc.titleSelective LC determination of cabergoline in the bulk drug and in tablets: In vitro dissolution studies
dc.typeMakale
dc.relation.journalCHROMATOGRAPHIA
dc.contributor.department, ,
dc.identifier.volume65
dc.identifier.startpage561
dc.identifier.endpage567
dc.contributor.firstauthorID65640


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster